Silverarc Capital Management, LLC Compugen LTD Transaction History

Silverarc Capital Management, LLC

$298 Million
Q1 2024

A detailed history of Silverarc Capital Management, LLC transactions in Compugen LTD stock. As of the latest transaction made, Silverarc Capital Management, LLC holds 1,000,000 shares of CGEN stock, worth $1.68 Million. This represents 0.87% of its overall portfolio holdings.

Number of Shares

1,000,000

Previous 940,000 6.38%

Holding current value

$1.68 Million

Previous $1.86 Million 38.64%

% of portfolio

0.87%

Previous 0.59%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	BUY	$1.75 - $2.95 $105,000 - $177,000	60,000 Added 6.38%	1,000,000 $2.58 Million
Q4 2023 Feb 14, 2024	BUY	$0.53 - $2.0 $312,600 - $1.18 Million	589,812 Added 168.43%	940,000 $1.86 Million
Q3 2023 Nov 13, 2023	BUY	$0.88 - $1.31 $17,600 - $26,200	20,000 Added 6.06%	350,188 $325,000
Q1 2023 May 15, 2023	SELL	$0.68 - $1.11 $229,333 - $374,353	-337,255 Reduced 50.53%	330,188 $231,000
Q4 2022 Feb 14, 2023	BUY	$0.65 - $1.2 $433,837 - $800,931	667,443 New	667,443 $480,000

Q2 2022 Jul 25, 2022	SELL	$1.57 - $3.33 $258,180 - $547,605	-164,446 Reduced 61.22%	104,150 $193,000
Q1 2022 May 13, 2022	BUY	$2.76 - $4.64 $292,543 - $491,812	105,994 Added 65.19%	268,596 $865,000
Q4 2021 Feb 14, 2022	SELL	$4.09 - $7.16 $167,403 - $293,058	-40,930 Reduced 20.11%	162,602 $699,000
Q3 2021 Nov 15, 2021	SELL	$5.8 - $8.02 $32,369 - $44,759	-5,581 Reduced 2.67%	203,532 $1.22 Million
Q2 2021 Aug 16, 2021	BUY	$6.87 - $9.16 $921,356 - $1.23 Million	134,113 Added 178.82%	209,113 $1.73 Million
Q1 2021 May 18, 2021	SELL	$7.67 - $13.77 $579,468 - $1.04 Million	-75,550 Reduced 50.18%	75,000 $644,000
Q4 2020 Feb 16, 2021	BUY	$12.07 - $17.95 $1.82 Million - $2.7 Million	150,550 New	150,550 $1.82 Million

Others Institutions Holding CGEN

# of Institutions

Shares Held

13.7M

Call Options Held

131K

Put Options Held

76K

View Full List

About COMPUGEN LTD

Ticker CGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 86,624,600
Market Cap $146M
Description
Compugen Ltd., a clinical-stage therapeutic discovery and development company, researches, develops, and commercializes therapeutic and product candidates in Israel, the United States, and Europe. The company's immuno-oncology pipeline consists of COM701, an anti-PVRIG antibody that is in Phase I clinical study used for the treatment of solid tu...

More about CGEN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Silverarc Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Silverarc Capital Management, LLC with notifications on news.

Account

Silverarc Capital Management, LLC Compugen LTD Transaction History